Sunday, August 2, 2026

U.S.-Korea Nuclear Submarine Deal: What to Expect from February Delegation?

The U.S. will send a delegation to South Korea to discuss nuclear cooperation, submarines, and shipbuilding agreements by February.

Ripple Sees 1% Price Surge Following CEO’s Meeting With Trump on Digital Asset Strategy

Ripple's CEO urges inclusion of cryptocurrencies in U.S. digital reserves, highlighting cooperation for industry growth.

AI Meets Railways: Why SR Is Partnering With a U.S. Startup to Rethink Train Operations

SR hosted an event with Gruve's CEO to enhance AI collaboration in railways, focusing on safety and efficiency improvements.

Health

Enhanced Recovery Protocol Speeds Recovery After Brain Aneurysm Surgery, Study Finds

Enhanced Recovery After Surgery (ERAS) can significantly improve recovery speed for patients undergoing brain aneurysm surgery.

Celltrion’s Omlyclo Gains Traction in Italy, Reinforcing Direct Sales Strategy as Growth Expected to Accelerate

Celltrion expands its biosimilar supply in Italy, enhancing its competitiveness in the European pharmaceutical market.

CG Bio Treats First U.S. Patient With Bone Graft Substitute, Advances FDA Approval

Sigibio accelerates clinical development for FDA approval after the first U.S. patient procedure with its next-gen bone substitute, Novosis Putty.

Is Winuf IV the Future of Nutritional IV Therapy? A Deep Dive into Omega-3’s Role in Healing

JW Pharmaceutical introduces clinical applications of omega-3 based nutrient infusion Winuf Inj. to medical professionals.

Next-Gen Surface Induction Radiation Therapy: A Game Changer for Breast Cancer Patients?

Breast cancer patients may soon avoid discomfort from tattoos or markings during radiation therapy.
Latest

3billion Launches Genome-Based Newborn Screening Service Overseas to Expand Early Genetic Diagnosis

3billion launches 3B-NEO, a genomic newborn screening service to identify genetic disorders in infants, enhancing early diagnosis and treatment.

Samjin Pharmaceutical and Aribio Lab Form Vaccine Partnership to Advance Joint Development and Commercialization

Samjin Pharmaceutical partners with Aribio Lab to develop and commercialize vaccines, enhancing market adoption and R&D capabilities.

Sam Chun Dang Pharm Wins EMA Approval for Phase 1 Trial of Oral Insulin Candidate SCD0503

Samchundang Pharmaceutical's oral insulin candidate 'SCD0503' received final approval for Phase 1 clinical trials from EMA.

Samsung Launches GLP-1 Muscle Loss Study With Galaxy Watch8 and Harvard-Linked Hospital

Samsung is researching muscle loss management for GLP-1 drug users, led by the Galaxy Watch 8.

Medical Innovation Committee Urges Hospitals to Embrace Decarbonization as Energy Security Threats Grow

The Healthcare Innovation Committee recommends decarbonization in healthcare to address energy security threats from the Middle East conflict.

Onconic Therapeutics Expands Zaqbo Development in China With Phase 3 Trial for H. pylori Eradication

Onconic Therapeutics' Zaqbo enters Phase 3 trials in China for H. pylori eradication, with strong revenue growth reported.

Seoul St. Mary’s Hospital Performs Korea’s First Single-Port Robotic Surgery for Plantar Hyperhidrosis

Seoul St. Mary's Hospital successfully performed Korea's first robotic surgery for plantar hyperhidrosis using a single-port robotic platform.

Celltrion Moves CT-G32 Into Final Preclinical Stage as Global Obesity Trial Preparation Accelerates

Celltrion advances CT-G32, a next-gen obesity treatment, targeting multiple pathways to enhance weight loss while preserving muscle mass.

Seoul St. Mary’s Prof. Jang Ki-yuk Selected as Sole Applied Medicine Researcher in National Leader Program

Prof. Jang Ki-yuk of Seoul St. Mary's Hospital receives $5.2M for cardiovascular disease research, focusing on plaque regression.

Researchers Identify Bone Age Differences Between Limbs in Rare Pediatric Overgrowth Disorders

A study reveals children with congenital hemihypertrophy show differing bone maturation rates, impacting surgical planning for limb discrepancies.

Metavia Highlights Strong Early Weight-Loss Data for DA-1726 at EASL 2026

MetaVia's obesity treatment candidate 'DA-1726' shows safety and weight loss effects in Phase 1 trials after 54 days.

Bundibugyo Ebola Outbreak Triggers WHO Emergency Declaration and Heightened South Korean Response Measures

WHO declares a Public Health Emergency of International Concern over Ebola outbreak in the Democratic Republic of Congo, raising global tensions.

Daewoong Pharmaceutical Partners With Seers and TR to Develop Integrated Smart Ward Respiratory Care Solution

Daewoong Pharmaceutical signed an MOU with Cears and TR for the expansion of digital healthcare solutions.

Frequent Delivery Meals and Abdominal Obesity Emerging as Key Drivers of Early Hypertension Risk

Increased use of delivery apps and late-night eating habits are raising hypertension and metabolic disease risks among young adults.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.